MOXIFLOXACIN HYDROCHLORIDE eye drops solution
Product Description
Rafarm S.A
-
GR
-
2015On CPHI since
Categories
Rafarm S.A
-
GR
-
2015On CPHI since
More Products from Rafarm S.A (38)
-
Product TOBRAMYCIN + DEXAMETHASONE eye drops suspension
Strength: (3 mg+1 mg)/ml Presentation: vials, 5 ml Therapeutic area: Intraocular inflammation & ocular surface bacterial contamination Innovator: Tobradex (Alcon-Novartis) -
Product TRAVOPROST + TIMOLOL eye drops solution
Strength: (40 mcg+5 mg)/ml Presentation: vials, 2.5 ml Therapeutic area: Glaucoma & Ocular Hypertension Innovator: DuoTrav (Alcon-Novartis) -
Product TRAVOPROST eye drops solution
Strength: 40 mcg/ml Presentation: vials, 2.5 ml Therapeutic area: Glaucoma & Ocular Hypertension Innovator: Travatan (Alcon-Novartis) -
Product ZOLEDRONIC ACID concentrate solution for infusion
Strength: 4 mg/5 ml Presentation: vials, 5 ml Therapeutic area: Skeletal Related Events in Advanced Malignancies & Tumour-Induced Hypercalcaemia Innovator: Zometa (Novartis) -
Product ROSUVASTATIN CALCIUM f.c. tablets
Strength: 5 mg/tab; 10 mg/tab; 20 mg/tab Therapeutic area: Hypercholesterolaemia & Prevention of Cardiovascular Events Innovator: Crestor (AstraZeneca) -
Product TOBRAMYCIN eye drops solution
Strength: 3 mg/ml Presentation: vials, 5 ml Therapeutic area: Bacterial Infections Innovator: Tobrex (Alcon) -
Product CLOPIDOGREL BESILATE f.c. tablets
Strength: 75 mg/tab Therapeutic area: Anti-thrombotic Innovator: Plavix (Sanofi-Aventis) -
Product AMIKACIN solution for injection
Strength: 500 mg/2 ml Presentation: vials, 2 ml Therapeutic area: Anti-infective Innovator: Briklin -
Product ATORVASTATIN f.c. tablets
Strength: 10 mg/tab; 20 mg/tab; 40 mg/tab; 80 mg/tab Therapeutic area: Hypercholesterolaemia & Prevention of Cardiovascular Diseases Innovator: Lipitor (Pfizer) -
Product BIMATOPROST + TIMOLOL eye drops solution
Strength: (0.3 mg+5 mg)/ml Presentation: vials, 3 ml Therapeutic area: Glaucoma & Ocular Hypertension Innovator: Ganfort (Allergan) -
Product BIMATOPROST eye drops solution
Strength: 0.3 mg/ml; 0.1 mg/ml Presentation: vials, 3 ml Therapeutic area: Glaucoma & Ocular Hypertension Innovator: Lumigan (Allergan) -
Product BRIMONIDINE + TIMOLOL eye drops solution
Strength: (2 mg+5 mg)/ml Presentation: vials, 5 ml Therapeutic area: Glaucoma & Ocular Hypertension Innovator: Combigan (Allergan)
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance